Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020581
Filing Date
2023-05-10
Accepted
2023-05-10 16:26:34
Documents
79
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sctl-20230331.htm   iXBRL 10-Q 1666721
2 EX-3.1 sctl-ex3_1.htm EX-3 281107
3 EX-4.1 sctl-ex4_1.htm EX-4 277679
4 EX-10.1 sctl-ex10_1.htm EX-10 170735
5 EX-31.1 sctl-ex31_1.htm EX-31 17119
6 EX-31.2 sctl-ex31_2.htm EX-31 17097
7 EX-32.1 sctl-ex32_1.htm EX-32 10420
  Complete submission text file 0000950170-23-020581.txt   8627318

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sctl-20230331_pre.xml EX-101.PRE 385778
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sctl-20230331_cal.xml EX-101.CAL 52251
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sctl-20230331.xsd EX-101.SCH 54208
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sctl-20230331_lab.xml EX-101.LAB 524298
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sctl-20230331_def.xml EX-101.DEF 215664
73 EXTRACTED XBRL INSTANCE DOCUMENT sctl-20230331_htm.xml XML 1366935
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Societal CDMO, Inc. (Filer) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 23906890
SIC: 2834 Pharmaceutical Preparations